Valuation : ResMed, Inc.

Market Cap 32.67B 28.09B 26.42B 24.12B 45.11B 3,090B 45.26B 313B 121B 1,582B 123B 120B 5,040B P/E 2027 *
19.6x
P/E 2028 * 17.9x
Enterprise Value 31.71B 27.27B 25.65B 23.42B 43.79B 2,999B 43.94B 304B 118B 1,536B 119B 116B 4,892B EV / Sales 2027 *
5.46x
EV / Sales 2028 * 5x
Free-Float
75.13%
Yield 2027 *
1.16%
Yield 2028 * 1.28%
1 day-2.58%
1 week-3.73%
Current month-7.24%
1 month+1.21%
3 months+15.32%
6 months-11.94%
Current year-7.54%
1 week 222.11
Extreme 222.11
237.21
1 month 210.58
Extreme 210.58
242.4
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Sell

Founder

-970 0.0007%
7/8/26 Exercice

Chief Executive Officer

14,973 0.0103%
5/8/26 Sell

Founder

-8,000 0.0055%
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%-3.73%-20.30%+50.54% 32.67B
-1.52%+0.31%+23.53%+16.23% 227B
-0.50%-0.33%+3.84%-16.95% 146B
-4.64%-4.07%-24.63%+18.78% 130B
-4.71%-4.02%-57.33%-14.34% 69.27B
-3.67%-4.03%+8.57%+17.56% 51.82B
+0.65%-1.30%-18.41%-13.16% 49.99B
-2.67%-2.43%+14.17%+28.33% 42.53B
-1.45%-0.66%+30.31%+52.96% 40.22B
-2.29%+2.83%+116.95%+34.50% 32.95B
Average -2.35%-1.34%+7.67%+17.44% 82.19B
Weighted average by Cap. -2.23%-1.55%+3.98%+10.98%

Financials

2027 *2028 *
Net sales 5.81B 5B 4.7B 4.29B 8.02B 550B 8.05B 55.73B 21.54B 281B 21.82B 21.34B 896B 6.19B 5.32B 5.01B 4.57B 8.55B 585B 8.57B 59.36B 22.94B 300B 23.24B 22.74B 955B
Net income 1.64B 1.41B 1.33B 1.21B 2.27B 155B 2.28B 15.76B 6.09B 79.59B 6.17B 6.04B 254B 1.78B 1.53B 1.44B 1.32B 2.46B 168B 2.47B 17.09B 6.6B 86.28B 6.69B 6.54B 275B
Net Debt -954M -821M -772M -705M -1.32B -90.26B -1.32B -9.15B -3.54B -46.22B -3.58B -3.51B -147B -1.69B -1.46B -1.37B -1.25B -2.34B -160B -2.35B -16.23B -6.28B -81.98B -6.36B -6.22B -261B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
08/09/26 US$222.29 -2.65% 135,697
04/09/26 US$228.35 -0.37% 843,837
03/09/26 US$229.19 -0.73% 1,483,411
02/09/26 US$230.87 -0.21% 1,156,476
01/09/26 US$231.36 -3.64% 987,078
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
228.35USD
Average target price
246.12USD
Spread / Average Target
+7.78%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!